Chelation therapy, particularly using EDTA, has shown potential benefits for patients with cardiovascular disease, especially those with diabetes and a history of myocardial infarction, as evidenced by the Trial to Assess Chelation Therapy (TACT). This treatment works by binding to heavy metals and minerals in the body, potentially improving blood
